CV
Covalon Technologies Ltd.
CVALF · OTC
$2.89 +2.21% (+$0.06)
1M +69.66%
Market Cap $109.2M
P/E Ratio 24.87x
Div. Yield 3.78%
ROE 15.05%
Bulios Fair Price
$1.9
34.3% downside
Current Price
$2.89
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CVALF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
50 /100
Fair P/E 24.87x
EV/EBITDA 19.54x
P/S 3.18x
Growth
93 /100
Growing Rev. growth 21.83%
Book val. growth 8.24%
EPS growth N/A
Profitability
79 /100
Strong Gross margin 58.09%
Net margin 12.78%
Op. margin 11.49%
Quality
73 /100
Excellent ROIC 11.88%
ROE 15.05%
ROA 12.00%
Debt
100 /100
Low Debt/Equity 0.05x
Current ratio 8.56x
Net debt/EBITDA -3.78x
Stability
21 /100
Unstable Beta 0.03x
Rev. volatility 21.24%
EPS volatility 97.19%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CVALF
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Brent Ashton
Employees
105
Headquarters
Mississauga
Upcoming events
10 DEC
Earnings
Upcoming earnings report